Atossa Genetics Stock Net Income
| ATOS Stock | USD 0.68 0.01 1.45% |
As of the 28th of January, Atossa Genetics shows the Mean Deviation of 3.06, risk adjusted performance of (0.06), and Standard Deviation of 4.1. Atossa Genetics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Atossa Genetics variance and potential upside to decide if Atossa Genetics is priced correctly, providing market reflects its regular price of 0.68 per share. As Atossa Genetics is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Atossa Genetics Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -23 M | -21.8 M | |
| Net Loss | -23 M | -24.1 M | |
| Net Loss | -24.3 M | -25.5 M | |
| Net Loss | (0.18) | (0.19) | |
| Net Income Per E B T | 1.11 | 0.90 |
Atossa | Net Income | Build AI portfolio with Atossa Stock |
Latest Atossa Genetics' Net Income Growth Pattern
Below is the plot of the Net Income of Atossa Genetics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Atossa Genetics financial statement analysis. It represents the amount of money remaining after all of Atossa Genetics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Atossa Genetics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (25.5 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Atossa Net Income Regression Statistics
| Arithmetic Mean | (15,176,743) | |
| Coefficient Of Variation | (57.64) | |
| Mean Deviation | 7,227,051 | |
| Median | (15,760,323) | |
| Standard Deviation | 8,747,311 | |
| Sample Variance | 76.5T | |
| Range | 30M | |
| R-Value | (0.88) | |
| Mean Square Error | 18.4T | |
| R-Squared | 0.77 | |
| Slope | (1,524,490) | |
| Total Sum of Squares | 1224.2T |
Atossa Net Income History
Other Fundumenentals of Atossa Genetics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Atossa Genetics Net Income component correlations
Atossa Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Atossa Genetics is extremely important. It helps to project a fair market value of Atossa Stock properly, considering its historical fundamentals such as Net Income. Since Atossa Genetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Atossa Genetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Atossa Genetics' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atossa Genetics is measured differently than its book value, which is the value of Atossa that is recorded on the company's balance sheet. Investors also form their own opinion of Atossa Genetics' value that differs from its market value or its book value, called intrinsic value, which is Atossa Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atossa Genetics' market value can be influenced by many factors that don't directly affect Atossa Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atossa Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atossa Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atossa Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Atossa Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atossa Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atossa Genetics.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Atossa Genetics on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Atossa Genetics or generate 0.0% return on investment in Atossa Genetics over 90 days. Atossa Genetics is related to or competes with Oncolytics Biotech, Tevogen Bio, Greenwich Lifesciences, Instil Bio, Immix Biopharma, Whitehawk Therapeutics, and Clene. Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medic... More
Atossa Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atossa Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atossa Genetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 20.34 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.78 |
Atossa Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atossa Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atossa Genetics' standard deviation. In reality, there are many statistical measures that can use Atossa Genetics historical prices to predict the future Atossa Genetics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.19) |
Atossa Genetics January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.18) | |||
| Mean Deviation | 3.06 | |||
| Coefficient Of Variation | (1,097) | |||
| Standard Deviation | 4.1 | |||
| Variance | 16.78 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.19) | |||
| Maximum Drawdown | 20.34 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.78 | |||
| Skewness | (0.25) | |||
| Kurtosis | 1.24 |
Atossa Genetics Backtested Returns
Atossa Genetics secures Sharpe Ratio (or Efficiency) of -0.0807, which signifies that the company had a -0.0807 % return per unit of risk over the last 3 months. Atossa Genetics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Atossa Genetics' Risk Adjusted Performance of (0.06), mean deviation of 3.06, and Standard Deviation of 4.1 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.06, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Atossa Genetics will likely underperform. At this point, Atossa Genetics has a negative expected return of -0.34%. Please make sure to confirm Atossa Genetics' potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Atossa Genetics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Atossa Genetics has good predictability. Overlapping area represents the amount of predictability between Atossa Genetics time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atossa Genetics price movement. The serial correlation of 0.72 indicates that around 72.0% of current Atossa Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Atossa Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Atossa Genetics reported net income of (25.5 Million). This is 107.47% lower than that of the Health Care Equipment & Supplies sector and 136.41% lower than that of the Health Care industry. The net income for all United States stocks is 104.47% higher than that of the company.
Atossa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atossa Genetics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atossa Genetics could also be used in its relative valuation, which is a method of valuing Atossa Genetics by comparing valuation metrics of similar companies.Atossa Genetics is currently under evaluation in net income category among its peers.
Atossa Genetics Institutional Holders
Institutional Holdings refers to the ownership stake in Atossa Genetics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atossa Genetics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atossa Genetics' value.| Shares | Goldman Sachs Group Inc | 2025-06-30 | 335 K | Susquehanna International Group, Llp | 2025-06-30 | 273.9 K | Northern Trust Corp | 2025-06-30 | 263.4 K | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 198.7 K | Squarepoint Ops Llc | 2025-06-30 | 181.1 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 160.9 K | Aster Capital Management (difc) Ltd | 2025-06-30 | 144.9 K | Jain Global Llc | 2025-06-30 | 123.1 K | Bank Of America Corp | 2025-06-30 | 99.6 K | Vanguard Group Inc | 2025-06-30 | 5.8 M | Ameriprise Financial Inc | 2025-06-30 | 3 M |
Atossa Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 36.61 M | ||||
| Shares Outstanding | 129.17 M | ||||
| Shares Owned By Insiders | 0.32 % | ||||
| Shares Owned By Institutions | 19.46 % | ||||
| Number Of Shares Shorted | 2.31 M | ||||
| Price To Earning | (0.62) X | ||||
| Price To Book | 1.78 X | ||||
| EBITDA | (27.6 M) | ||||
| Net Income | (25.5 M) | ||||
| Cash And Equivalents | 125.54 M | ||||
| Cash Per Share | 0.99 X | ||||
| Total Debt | 4.97 M | ||||
| Current Ratio | 35.19 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | (21.03 M) | ||||
| Short Ratio | 1.69 X | ||||
| Earnings Per Share | (0.23) X | ||||
| Target Price | 5.75 | ||||
| Number Of Employees | 15 | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 88.46 M | ||||
| Total Asset | 76.44 M | ||||
| Retained Earnings | (211.79 M) | ||||
| Working Capital | 69.49 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 2.5 M | ||||
| Net Asset | 76.44 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.